Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 27, Number 9—September 2021
Synopsis

Seroprevalence and Virologic Surveillance of Enterovirus 71 and Coxsackievirus A6, United Kingdom, 2006–2017

Everlyn KamauComments to Author , Dung Nguyen, Cristina Celma, Soile Blomqvist, Peter Horby, Peter Simmonds, and Heli Harvala
Author affiliations: University of Oxford, Oxford, UK (E. Kamau, D. Nguyen, P. Horby, P. Simmonds); Public Health England, London, UK (C. Celma); National Institute for Health and Welfare, Helsinki, Finland (S. Blomqvist); National Health Service Blood and Transplant, London, UK (H. Harvala); University College London, London, UK (H. Harvala)

Main Article

Figure 3

EV-A71(A) and CVA6 (B)seroprevalence in England, UK, in 2006, 2011, and 2017, by age group. Results are expressed as percentage of samples displaying neutralizing antibody titers <8 to >1,024 (colored bars). Red dots represent point estimates of the seropositive proportion; error bars indicate 95% CI. Samples were scored seropositive if neutralization was achieved at serum dilution of >1:8. CVA6, coxsackievirus A6; EV-A71, enterovirus A71.

Figure 3. EV-A71(A) and CVA6 (B)seroprevalence in England, UK, in 2006, 2011, and 2017, by age group. Results are expressed as percentage of samples displaying neutralizing antibody titers <8 to >1,024 (colored bars). Red dots represent point estimates of the seropositive proportion; error bars indicate 95% CI. Samples were scored seropositive if neutralization was achieved at serum dilution of >1:8. CVA6, coxsackievirus A6; EV-A71, enterovirus A71.

Main Article

Page created: July 15, 2021
Page updated: August 17, 2021
Page reviewed: August 17, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external